Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.

about

Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes Demystifying the management of hypertriglyceridaemia.Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet.

P2860

Q36607551-5D64797D-0324-4A7E-A25C-672754FF1FA6 Q38141575-83F85146-FA77-4AE7-AC96-18503894B3B3 Q51289884-7815D02F-4AA3-40C3-840D-B003710E5CFF

P2860

Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.

Item

http://www.wikidata.org/entity/Q41886525

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Novel insights into the regula ...... es: significance for diabetes.

@en

type

Item

label

Novel insights into the regula ...... es: significance for diabetes.

@en

prefLabel

Novel insights into the regula ...... es: significance for diabetes.

@en

P1476

Novel insights into the regula ...... es: significance for diabetes.

@en

P2093

Dick C Chan

http://www.w3.org/2001/XMLSchema#string

Gerald F Watts

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Minireview: the glucagon-like peptides.

Glucagon-like peptide 2.

Glucagon-like peptide-2: update of the recent clinical trials.

Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.

Mechanism of intestinal lipoprotein overproduction in insulin resistant humans.

Ileal brake: a sensible food target for appetite control. A review.

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.

Gut-liver interaction in triglyceride-rich lipoprotein metabolism.

Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states.

P304

336-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-1098

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235371896

http://www.w3.org/2001/XMLSchema#string

P698

23349538

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

P932

3554347

http://www.w3.org/2001/XMLSchema#string

Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.

about

P2860

P2860

Novel insights into the regulation of postprandial lipemia by glucagon-like peptides: significance for diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932